Quest Diagnostics Reports First Quarter 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/27/2026
- S&P 500 ends lower; chips tumble and Moderna rallies
- SpaceX weighs Starlink mobile service to US consumers, FT reports
- U.S. chip stocks retreat after Apple price hikes stoke fears over AI trade
- Morgan Stanley flags Fed hike risk if unemployment drops below 4%
- UBS trims AI portfolio exposure to semis and hardware after recent rally
Quest Diagnostics (DGX) Tops Q1 EPS by 4c, Revenues Beat
April 22, 2020 6:46 AM EDTQuest Diagnostics (NYSE: DGX) reported Q1 EPS of $0.94, $0.04 better than the analyst estimate of $0.90. Revenue for the quarter came in at $1.82 billion versus the consensus estimate of $1.76 billion.
"We were very pleased with Quest's results in January and February, which were consistent with the full-year guidance we provided in January," said Steve Rusckowski, Chairman, CEO and President. "However, in March, we experienced a material decline in testing volumes due to the COVID-19 pandemic. During the last... More
